Trump may be mystery patient in odd case of 79yo getting experimental obesity drug
In an extremely odd case, a single 79-year-old patient was granted early access to Eli Lilly’s powerful, still-experimental obesity drug retatrutide through the Food and Drug Administration’s “compassionate use” program—raising immediate questions if that sole patient is President Donald Trump, according to a report by Stat News.
Lilly’s retatrutide is a highly anticipated next-generation obesity drug that targets GIP and glucagon hormones in addition to GLP-1. It is currently in late-stage trials to treat obesity, diabetes, sleep apnea, and other conditions. Data from a Phase 3 trial that Lilly released in May indicates that patients with obesity (but without diabetes) who took the drug for 80 weeks lost 28 percent of their weight, an amount comparable to bariatric surgery.
Millions of Americans with obesity are eager to get the drug, with options being limited so far to enrolling in a clinical trial or trying to obtain it by dodgy methods.
But according to a barebones public notice and Stat’s sources, a single person has been granted early access through the expanded access, aka “compassionate use” pathway, which is typically used to grant access to patients with a “serious or immediately life-threatening disease or condition” and who are not able to enroll in a clinical trial, often because they are too ill.
https://arstechnica.com/health/2026/06/trump-may-be-mystery-patient-in-odd-case-of-79yo-getting-experimental-obesity-drug/Open linkView original on sh.itjust.works
"a single person has been granted early access through the expanded access, aka “compassionate use” pathway, which is typically used to grant access to patients with a “serious or immediately life-threatening disease or condition” and who are not able to enroll in a clinical trial, often because they are too ill."
Nope, not falling for that. The entitled tubby brat just wants to jump the queue.
Are the other people in the study named? Is the 79yo the only unnamed person? If so that is suspicious
This isn't about a standard clinical trial/study getting a non-standard unnamed patient (that's exactly what this program is intended for), and patient names aren't publicized anyway. This is the only person given access to the drug outside of the clinical trial, period. AND it is missing most of the regular non-identifying information that would accompany that (probably because that normally non-identifying info would almost surely identify the President given how obviously unhealthy he is despite the propaganda about his health.
Only one person was given early access to the drug, that person wasn't in the study.